Edwards Lifesciences Corporation Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase
Edwards Lifesciences Corporation (EW) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase of 2.80% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease · last filed 2026-02-25
- Edwards Lifesciences Corporation defined benefit plan, assumptions used calculating net periodic benefit cost, rate of compensation increase for fiscal 2025 was 2.80%, a 3.45% decline from fiscal 2024.
- Edwards Lifesciences Corporation defined benefit plan, assumptions used calculating net periodic benefit cost, rate of compensation increase for fiscal 2024 was 2.90%, a 0.00% change from fiscal 2023.
- Edwards Lifesciences Corporation defined benefit plan, assumptions used calculating net periodic benefit cost, rate of compensation increase for fiscal 2023 was 2.90%, a 11.54% increase from fiscal 2022.
- Edwards Lifesciences Corporation defined benefit plan, assumptions used calculating net periodic benefit cost, rate of compensation increase for fiscal 2022 was 2.60%.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase 12 month |
|---|---|
| 2025-12-31 | 2.80% 10-K · filed 2026-02-25 |
| 2024-12-31 | 2.90% 10-K · filed 2026-02-25 |
| 2023-12-31 | 2.90% 10-K · filed 2026-02-25 |
| 2022-12-31 | 2.60% 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |